✉news BusinessStartups first seen 5 d ago, last 5 d ago, peak #36
Kevin Weil leaves OpenAI to launch drug discovery startup
Original: Kevin Weil leaves OpenAI and raises $215 million for drug discovery startup
Kevin Weil has left OpenAI and raised $215 million for a new drug discovery startup, according to Fortune. The move marks a shift from artificial intelligence to applying advanced computing to pharmaceutical research. The size of the funding round so early in the company's life is drawing attention across the tech and biotech communities.
Why now: A high-profile OpenAI executive's departure and large funding round signal growing investor interest in AI-driven drug discovery.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/3260632